查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1983175

血流动力学监测系统市场：按产品类型、应用、最终用户和地区划分

Hemodynamic Monitoring Systems Market, By Product Type, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2026 年，血液动力学监测系统市场规模将达到 14.238 亿美元，到 2033 年将达到 22.267 亿美元。预计从 2026 年到 2033 年，该市场将以 6.6% 的复合年增长率成长。

分析范围 分析详情
基准年 2025 市场规模（2026 年） 14.238亿美元
效能数据 2020-2024 预测期 2026-2033
预测期（2025-2032 年）复合年增长率 6.60% 预计金额（2033 年） 22.267亿美元

血流动力学监测是指利用血流动力学系统持续监测静脉、动脉和心臟的血流状况。血流动力学监测系统用于测量静脉、心臟和动脉的血压。它们还可以监测心臟健康状况，并测量血流量和血氧水平。血流监测有三种方法：有创、非侵入性和微创。先进的血流动力学监测解决方案利用各种感测器、导管、软体和血流动力学监测系统，以帮助主动应对危急情况。血流动力学监测系统与治疗通讯协定结合，可改善患者预后。血流动力学监测系统提供的临床资讯可以影响医疗决策，进而改善病人预后。所有入住加护病房 (ICU) 的患者都需要进行标准的基本血流动力学监测（心电图、心率、血压、中心静脉压、体温、週边静脉血氧饱和度和血气分析）。所有重症患者都需要监测血管内容量，并定期观察其摄取量和排放。

市场动态

预计在预测期内，主要企业推出新产品等非内生性成长策略将推动全球血流动力学监测系统市场的发展。例如，2019年12月，医疗用电子设备製造商日本光电株式会社宣布推出携带式生命征象监测系统LifeScope SVM-7200。该产品整合了生命体征数据和观察数据，使医生能够快速评估患者病情。它还可以测量血氧饱和度、血压和体温。

本报告的主要特点

  • 本报告对全球血流动力学监测系统市场进行了详细分析，包括预测期（2025-2032 年）的市场规模和复合年增长率，以 2024 年为基准年。
  • 此外，它还确定了每个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
  • 此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
  • 本文根据以下参数，介绍了全球血流动力学监测系统市场主要企业的概况：公司概况、产品系列、主要亮点、财务绩效和策略。
  • 本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
  • 《全球血流动力学监测系统市场》报告针对该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过分析全球血流动力学监测系统市场中使用的各种策略矩阵来促进决策。

目录

第一章：分析目标与假设

  • 分析目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章：市场动态、监管与趋势分析

  • 市场动态
    • 促进因素
    • 抑制因子
    • 市场机会
  • 影响分析
  • 市场趋势
  • 近期趋势
  • 企业合併情景
  • 技术介绍
  • 法规环境
  • PEST分析

第四章 全球血流动力学监测系统市场：依产品类型划分（2026-2033 年）

  • 生命征象监测
  • 脉搏血氧饱和度分析仪
  • 非侵入性血压监测器
  • 中央静脉导管
  • 肺动脉导管

第五章 全球血流动力学监测系统市场：依应用领域划分（2026-2033 年）

  • 有创血流动力学监测
  • 非侵入性血流动力学监测
  • 微创血流动力学监测

第六章 全球血流动力学监测系统市场：依最终使用者划分（2026-2033 年）

  • 医院
  • 诊所
  • 日间手术中心
  • 居家医疗
  • 独立导管检查室

第七章 全球血流动力学监测系统市场：按地区划分（2026-2033 年）

  • 北美洲
    • 我们
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 法国
    • 西班牙
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韩国
    • 亚太其他地区
  • 中东
    • GCC
    • 以色列
    • 其他中东国家
  • 非洲
    • 北非
    • 中非
    • 南非

第八章 竞争情势

  • Edwards Lifesciences Corporation
  • ICU Medical, Inc.
  • PULSION Medical Systems SE
  • Koninklijke Philips NV
  • General Electric
  • TytoCare Ltd.
  • Getinge AB.
  • Nonin
  • Masimo
  • Baxter
  • OMRON Corporation
  • B.Braun Melsungen AG
  • Medtronic
  • Dragerwerk AG &Co. KGaA
  • Nihon Kohden Corporation
  • Schwarzer Cardiotek GmbH
  • Osypka Medical GmbH
  • Tensys Medical Inc.

第九章

  • 分析方法
  • 关于 Coherent Market Insights
简介目录
Product Code: CMI1070

Hemodynamic Monitoring Systems Market is estimated to be valued at USD 1,423.80 Mn in 2026 and is expected to reach USD 2,226.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 1,423.80 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.60% 2033 Value Projection: USD 2,226.7 Mn

Hemodynamic monitoring is the continuous monitoring of the blood flow through the veins, arteries, and heart using hemodynamic systems. Hemodynamic monitoring system is used to measure the blood pressure inside the veins, heart, and arteries. It also monitors health of the heart and measures blood flow and amount of oxygen in the blood. There are three types of techniques utilized for blood flow monitoring such as invasive, non-invasive, and minimally invasive. Advanced hemodynamic monitoring solutions help to stay ahead of critical moments with a range of sensors, catheters, software, and hemodynamic monitoring systems. Hemodynamic monitoring systems coupled with treatment protocols can improve patient outcome. Hemodynamic monitoring system provide clinical information that may impact medical decision-making to improve patient outcome. All patients admitted to the ICU require standard basic hemodynamic monitoring (ECG, heart rate, blood pressure, central venous pressure, temperature, peripheral venous oxygen saturation, blood gas analysis). All critically ill patients need monitoring of intravascular volume status, and intake and output must regularly be observed.

Market Dynamics

Adoption of inorganic strategies such as product launches by the key market players is expected to drive the global hemodynamic monitoring systems market over the forecast period. For instance, in December 2019, Nihon Kohden Corporation, a manufacturer of medical electronic equipment, announced that they had launched the life scope SVM-7200 which is a portable vital signs monitoring system. It combines vital signs data and observational data that enables physicians to assess patient condition promptly. It also measures blood oxygen level, blood pressure and temperature.

Key features of the study

  • This report provides an in-depth analysis of the global hemodynamic monitoring systems market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global hemodynamic monitoring systems market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Edwards Lifesciences Corporation, ICU Medical, Inc., PULSION Medical Systems SE, Koninklijke Philips N.V., General Electric, TytoCare Ltd., Getinge AB., Nonin, Masimo, Baxter, OMRON Corporation, B. Braun Melsungen AG, Medtronic, Dragerwerk AG & Co. KGaA, Nihon Kohden Corporation, Schwarzer Cardiotek GmbH, Osypka Medical GmbH, and Tensys Medical Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global hemodynamic monitoring systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hemodynamic monitoring systems market

Market Segmentation

  • By Product Type
    • Vital Sign Monitors
    • Pulse Oximeters
    • Non-Invasive Blood Pressure Monitors
    • Central Venous Catheters
    • Pulmonary Artery Catheters
  • By Application
    • Invasive Hemodynamic Monitoring
    • Non-Invasive Hemodynamic Monitoring
    • Minimally Invasive Hemodynamic Monitoring
  • By End User
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Home Care Settings
    • Independent Catheterization Laboratories
  • By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Global Hemodynamic Monitoring Systems Market - Key Players
    • Edwards Lifesciences Corporation
    • ICU Medical, Inc.
    • PULSION Medical Systems SE
    • Koninklijke Philips N.V.
    • General Electric
    • TytoCare Ltd.
    • Getinge AB.
    • Nonin
    • Masimo
    • Baxter
    • OMRON Corporation
    • Braun Melsungen AG
    • Medtronic
    • Dragerwerk AG & Co. KGaA
    • Nihon Kohden Corporation
    • Schwarzer Cardiotek GmbH
    • Osypka Medical GmbH
    • Tensys Medical Inc

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Technology Introduction
  • Regulatory Scenario
  • PEST Analysis

4. Global Hemodynamic Monitoring Systems Market, By Product Type, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Vital Sign Monitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Pulse Oximeters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Non-Invasive Blood Pressure Monitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Central Venous Catheters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Pulmonary Artery Catheters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Hemodynamic Monitoring Systems Market, By Application, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Invasive Hemodynamic Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Non-Invasive Hemodynamic Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Minimally Invasive Hemodynamic Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Hemodynamic Monitoring Systems Market, By End User, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Ambulatory Surgery Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Independent Catheterization Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

7. Global Hemodynamic Monitoring Systems Market, By Region, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2026-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Edwards Lifesciences Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ICU Medical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • PULSION Medical Systems SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Koninklijke Philips N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • General Electric
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • TytoCare Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Getinge AB.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Nonin
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Masimo
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Baxter
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • OMRON Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • B.Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dragerwerk AG & Co. KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Nihon Kohden Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Schwarzer Cardiotek GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Osypka Medical GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Tensys Medical Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us